Howard Welgus

Former Professor & Chief of Dermatology at Barnes-Jewish Hospital

Howard Welgus

Howard Welgus

Former Professor & Chief of Dermatology at Barnes-Jewish Hospital

Overview
RelSci Relationships

4865

Number of Boards

3

Birthday

1953

Age

68

Relationships
RelSci Relationships are individuals Howard Welgus likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Arcutis Biotherapeutics, Inc.

Relationship likelihood: Strong

President & Director at American Dermatological Association, Inc.

Relationship likelihood: Strong

General Partner, Life Sciences Team at Frazier Healthcare Partners

Relationship likelihood: Strong

President & Chief Executive Officer at Arcutis Biotherapeutics, Inc.

Relationship likelihood: Strong

Former Executive Chairman, President & Chief Executive Officer at Thesan Pharmaceuticals, Inc.

Relationship likelihood: Strong

Post Doctorate, Department of Organic Chemistry at Yale University

Relationship likelihood: Strong

Chief Executive Officer at AMR Action Fund

Relationship likelihood: Strong

Venture Partner at Novartis Venture Fund

Relationship likelihood: Strong

Chief Executive Officer at Lundbeckfonden Ventures

Relationship likelihood: Strong

Managing Partner, Biotechnology at SV Health Investors LLC

Relationship likelihood: Strong

Paths to Howard Welgus
Potential Connections via
Relationship Science
You
Howard Welgus
Former Professor & Chief of Dermatology at Barnes-Jewish Hospital
Education

Rice University is a comprehensive research university that fosters diversity and an intellectual environment that produces the next generation of leaders and advances tomorrow’s thinking and is set in the heart of Houston, Texas, the nation’s fourth-largest city.

A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School's 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children's hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.

Memberships
Member
Current

American Society for Clinical Investigation is a private company headquartered in Ann Arbor, MI. The firm provides clinical investigation services.

Member
Current

American Dermatological Association, Inc. recognizes, discusses and develops solutions for problems in the area of dermatologic health care, research and education. The company was founded in 1876 and is headquartered in Fort Lauderdale, FL.

Career History
Professor & Chief of Dermatology
Tenure Unconfirmed

Barnes-Jewish Hospital provides healthcare services. It provides its medical services in the areas of cancer, clinics, dermatology, diabetes and endocrinology, digestive diseases, elder care and rehabilitation, emergency medicine, geriatrics, heart and vascular, lung diseases, nephrology, neurology and neurosurgery, obstetrics and gynecology, ophthalmology, orthopedic care, pain management, palliative care, plastic and reconstructive surgery, psychiatry, radiology, rheumatology, spine and spinal cord, transplant, trauma and acute care surgery, urology and wound/general surgery. The company was founded in 1996 and is headquartered in St. Louis, MO.

Chief Medical Officer
2017 - 2020

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Chief Medical Officer
2016 - 2018

Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Public Holdings
Restricted data only for RelSci Enterprise users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Howard Welgus. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Howard Welgus's profile does not indicate a business or promotional relationship of any kind between RelSci and Howard Welgus.